GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Phase Forward Incorporated (PFWD) [hlAlert]

Rating:
Sell PFWD
down 11.29 %

Phase Forward Incorporated (PFWD) downgraded to Sell by Dougherty & Company

Posted on: Monday,  Apr 19, 2010  8:25 AM ET by Dougherty & Company

Dougherty & Company rated Sell Phase Forward Incorporated (NASDAQ: PFWD) on 04/19/2010. Previously Dougherty & Company rated Buy Phase Forward Incorporated
(NASDAQ: PFWD) on 07/17/2008., when the stock price was $18.94. Since then, Phase Forward Incorporated has lost 11.30% as of 04/19/2010's recent price of $16.80.
If you would have followed the previous Dougherty & Company 's recommendation on PFWD, you would have lost 11.29% of your investment in 641 days.

Phase Forward is a provider of integrated enterprise-level software products, services, and hosted solutions for use in the clinical trial component of its customers' global research and development initiatives. Phase Forward's customers include pharmaceutical, biotechnology, and medical device companies, as well as academic institutions, clinical research organizations, and other entities engaged in clinical trials.

Team The research group is composed of five senior analysts and two associate analysts. The senior analysts collectively have 44 years of securities industry experience, and include 3 MBA's, 2 CPA's, 2 PE's (professional engineer), a CFA and a CMA. The team has come together out of a passion for overlooked or misunderstood investment opportunities – generally in smaller-cap companies – and a love of in-depth research, with special emphasis on independent information sources and innovative thinking. Coverage Our research coverage is idea driven and balances the twin demands of opportunism for flexibility and universe consistency for maximization of information sources. Current sub-sectors of interest include: * Specialty retail * Internet security * Internet media * Auto-identification and data capture (AIDC & RFID) * Mobile computing * Specialty manufacturing * Chronic care management * Outpatient services * Medical devices * Healthcare IT
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/19/2010 8:25 AM Sell
None
16.80
as of 12/31/2010
1 Week   
1 Month   
3 Months   
1 YTD up  8.38 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/17/2008 2:25 PM Buy
None
18.94 22.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy